Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/9309370

Download in:

View as

General Info

PMID
9309370